Related references
Note: Only part of the references are listed.Structural studies of B-type Aurora kinase inhibitors using computational methods
M. M. Neaz et al.
ACTA PHARMACOLOGICA SINICA (2010)
A Specific Pharmacophore Model of Aurora B Kinase Inhibitors and Virtual Screening Studies Based on it
Hui-Yuan Wang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Predicting pKa
Adam C. Lee et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: Selective inhibitors of Aurora B kinase with potent anti-tumor activity
Kevin M. Foote et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Molecular basis of drug resistance in Aurora kinases
Fiona Girdler et al.
CHEMISTRY & BIOLOGY (2008)
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis
Robert W. Wilkinson et al.
CLINICAL CANCER RESEARCH (2007)
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase
Andrew A. Mortlock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Knowledge-based chemoinformatic approaches to drug discovery
Arup K. Ghose et al.
DRUG DISCOVERY TODAY (2006)
Validating Aurora B as an anti-cancer drug target
Fiona Girdler et al.
JOURNAL OF CELL SCIENCE (2006)
Assessing the scaffold diversity of screening libraries
M Krier et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors
NM Heron et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors
FH Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Development of quantitative structure-activity relationships and its application in rational drug design
Guang-Fu Yang et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Aurora A and B kinases as targets for cancer: will they be selective for tumors?
Nick Matthews et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Progress in the development of selective inhibitors of aurora kinases (vol 5, pg 199, 2005)
A Mortlock et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Lessons in molecular recognition: The effects of ligand and protein flexibility on molecular docking accuracy
JA Erickson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm
GS Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
DoMCoSAR: A novel approach for establishing the docking mode that is consistent with the structure-activity relationship. Application to HIV-1 protease inhibitors and VEGF receptor tyrosine kinase inhibitors
M Vieth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
